Physician profile
Kelby G Maher
NPI 1023161965
$389.04
in general payments reported to CMS, 2019-2025
13 companies · $83.96 in 2025
The $83.96 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $42.37 · 2021: $29.00 · 2023: $40.88 · 2024: $55.49 · 2025: $83.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $51.50 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $49.08 | 2025 | |
| Sobi, INC | $44.14 | 2019 | |
| Merck Sharp & Dohme LLC | $42.74 | 2019-2024 | Gardasil, Rotateq, Gardasil 9 |
| Ironshore Pharmaceuticals INC. | $37.86 | 2019 | |
| Covis Pharma Gmbh | $29.00 | 2021 | |
| Tris Pharma INC | $28.74 | 2020 | |
| Verrica Pharmaceuticals INC. | $22.62 | 2023 | Ycanth |
| Cranial Technologies, INC | $20.73 | 2025 | Doc Band |
| Seqirus USA INC | $19.68 | 2024 | Flucelvax |
| Smith+Nephew, INC. | $14.86 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $14.15 | 2025 | Neffy |
| Mylan Pharmaceuticals INC. | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelby Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.